Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; and the Timiskaming District of northern Ontario. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.…
DiagnaMed Holdings Corp. Announces Refiling of Its Annual and Interim Financial Statements and related MD&A
Diagnamed Holdings (CNSX: DMED) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.0200 CAD on 20 November 2026, down 71.4% over 52 weeks. Its 52-week range is 0.0200 CAD to 0.2500 CAD, and it trades at the bottom of that range.
Its market capitalisation is 2.63M CAD.
Diagnamed Holdings reports return on equity of 311.7% and an operating margin of 0.0%.
It holds more cash than debt, a net cash position of 293.76K CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.
No upcoming events tracked.